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Introduction {#sec1}
============

Multipotent neural stem cells (NSCs) of the neural tube differentiate and populate the entire CNS. A small population of NSCs resides in a niche in the subventricular zone of the adult brain, for neurogenesis in response to injury. They are epithelial-like in morphology and undergo epithelial-to-mesenchymal transition when migrating in response to developmental or regenerative cues. The resultant self-renewing neural progenitor cells (NPCs), with features of transit amplifying cells, are capable of long-distance migration and terminal differentiation to mature neural cell types ([@bib33]). NSCs primarily rely on glycolysis for energy production, but mature neurons require mitochondrial oxidative phosphorylation (OXPHOS). At some point during neural commitment, there is a metabolic switch in glucose utilization that has not been clearly defined. Furthermore, macroautophagy (herein referred to as autophagy)---the intracellular degradation system---is important for maintaining nutrient homeostasis during neurogenesis; impairment in autophagy results in neural tube defects in mice ([@bib7]).

It is clear that nuclear factor κB (NF-κB) activity plays a role in neural differentiation during perinatal development ([@bib26], [@bib35]) and throughout adulthood ([@bib4]). However, there is ambiguity in terms of its longitudinal molecular function. Recent studies in murine pathogenic models have implicated NF-κB activation in NSC commitment ([@bib5], [@bib20], [@bib30], [@bib40]). NF-κB has previously been associated with metabolic reprogramming in stem cells and cancer ([@bib14], [@bib15], [@bib24]), but its involvement in metabolic and autophagic reprogramming in human embryonic neurogenesis has not yet been elucidated. Here, we use a five-stage neural differentiation protocol using human pluripotent stem cells to interrogate NF-κB activity and function during neurogenesis. We find that NF-κB orchestrates a maturation program involving alterations in metabolism, autophagy, and cell cycle.

Results {#sec2}
=======

Validation of Our Stage-Wise *In Vitro* Neural Differentiation Protocol {#sec2.1}
-----------------------------------------------------------------------

We first designed a five-stage neural differentiation protocol from pluripotency based largely on self-organization with minimal growth factor application to avoid exogenous stimulation (summarized in [Figure 1](#fig1){ref-type="fig"}A) ([@bib2], [@bib6], [@bib38]). The human embryonic stem cell (hESC) line Shef3 (obtained from the UK Stem Cell Bank under the project SCSC10-48) was progressively differentiated through stages aligning to neuroepithelial clusters (NECs), neural rosette-forming progenitor cells (NRPCs), committed NPCs, and mature neurons ([Figure 1](#fig1){ref-type="fig"}B). When neural rosettes were mechanically isolated and replated, migrating cells with a mesenchymal morphology rapidly assumed a SOX2^−^/Nestin^+^ phenotype ([Figures 1](#fig1){ref-type="fig"}C and D). As neural differentiation progressed, pluripotency markers such as OCT4 and Tra-1-81 were no longer apparent, and SOX2 and Nestin expression also decreased in terminally differentiated cells ([Figures S1](#mmc1){ref-type="supplementary-material"}A and [S6](#mmc1){ref-type="supplementary-material"}).Figure 1Evaluation of Stage-Wise Targeted Differentiation of hESCs to Mature Neurons(A) Schematic representation of our five-stage differentiation protocol.(B and C) Morphological evaluation (B) and immunocytochemical validation (C) of (i) embryonic stem cells (SOX2), (ii) neuroepithelial cells, (iii) neural rosette-forming progenitor cells, (iv) neural progenitor cells (all Nestin), and (v) neuronal cell cultures (β-III-tubulin). Scale bar, 100 μm.(D) Co-immunocytochemistry shows SOX2^+^/Nestin^+^ neural rosette structures and adjacent SOX2^−^/Nestin^+^ committed migratory cells (arrows). Scale bars, 100 μm.(E) Transcriptomic analysis of our stage-wise neural differentiation.(F) qRT-PCR validation of transcriptional expression of the neural stem cell markers (i) *LIN28A* and (ii) *SOX2* gene expression during neural specification (n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01; error bars, ±SEM).

Transcriptomic Evaluation of hESC Neural Differentiation {#sec2.2}
--------------------------------------------------------

Global gene expression was compared using Illumina microarray across our neural differentiation protocol. Hierarchical clustering of biological repeats demonstrated that cells at the NEC and NRPC stages were most similar and had a transcriptome more similar to ESCs than NPCs ([Figure S1](#mmc1){ref-type="supplementary-material"}B). As we would predict, the pluripotency-associated transcripts for *OCT4* and *Nanog* were downregulated gradually over differentiation and became undetectable by the NPC stage. *SOX2* and *LIN28* expression are associated with both pluripotency and NSC maintenance. Transcriptomics and qRT-PCR confirmed expression of both was maintained in NRPCs before dropping to undetectable levels in NPCs ([Figures 1](#fig1){ref-type="fig"}E, 1Fi, and 1Fii). The highest expression of *Nestin* and *PAX6* transcripts was at the NRPC stage whereas markers of a more committed neural phenotype; *Vimentin* and *CDH2*, were highest at the NPC stage. Markers of endodermal (such as *SOX17*, *GATA4*, and *HNF1*) and mesodermal specification (*Goosecoid*, *MIXL1*, and *Eomes*) were unchanged during our neural specification protocol. These data validated our neurogenesis model. Analysis of regionalization suggested that NPCs are hindbrain precursors, most likely due to continued culture in fibroblast growth factor (FGF) throughout expansion ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

Metabolic reprogramming occurs during the differentiation of pluripotent stem cells to neurons, so we interrogated our transcriptomic dataset for indicators of this process. Our dataset showed that transcripts encoding proteins involved in glycolysis were strongly represented up to and including NRPCs but were reduced in committed NPCs. We saw an inverse correlation of transcripts associated with mitochondrial biogenesis. Interestingly, transcripts encoding proteins involved in the tricarboxylic acid (TCA) cycle, responsible for mitochondrial respiration, were not universally upregulated between NRPCs and NPCs. We also evaluated the anabolic utilization of glucose through the pentose phosphate pathway (PPP). Although there was not unilateral upregulation of PPP transcripts, the rate-limiting enzyme glucose-6-phosphate dehydrogenase (*G-6-PD*) was increased between NRPC and NPC, suggesting that there could be an increase in PPP activity as cells commit to the NPC phenotype ([Figure 1](#fig1){ref-type="fig"}E).

Gene Ontogeny of NF-κB Activity in Differentiating Cultures {#sec2.3}
-----------------------------------------------------------

Gene ontogeny analysis of our transcriptomic dataset (KEGG and PANTHER) showed that "TNFα signaling," "inflammation," "cytokine signaling," and more specifically "NF-κB targets" were collectively the most over-represented cellular processes during NPC commitment from NRPC ([Figures 2](#fig2){ref-type="fig"}A and 1E; [Table S2](#mmc2){ref-type="supplementary-material"}). Normalized average array signals for classical canonical NF-κB signal transducers and transcriptional targets (*IL6/8*, *MMP9*, *CCL2*) were significantly increased in NPCs compared with NRPCs. Signal transduction of canonical NF-κB concludes with nuclear translocation of the p50/p65 heterodimer, which binds to DNA consensus sites at gene regulatory sites and activates transcription. Upregulation of the p50 precursor NFKB1, and metabolism associated NF-κB transcriptional target *NQO1*, in NPCs compared with NRPCs, were confirmed by qRT-PCR ([Figure 2](#fig2){ref-type="fig"}B). Similarly, we developed a script for meta-analysis (R studio and Linux) to isolate correlation coefficients with p65 in open-access mouse neural differentiation arrays. Analysis of the top 500 genes associated with p65 (correlation coefficients ranged from 0.82 to 0.53) using EnrichR (KEGG2015) resulted in the "oxidative phosphorylation" category obtaining the highest combined score (p = 0.0002). In the context of neural differentiation, genes such as ATP synthases and ubiquinol-cytochrome *c* reductases were found to show high correlation with p65 expression as well as a number of NADH dehydrogenases. PANTHER analysis of the largest group (213 of the 452 genes identified) represented genes contributing to metabolic processes ([Figure 2](#fig2){ref-type="fig"}C).Figure 2Gene Ontology Analysis of Illumina HT-12 Microarray and Publicly Available Datasets(A) PANTHER and KEGG pathway analysis of our transcriptomic dataset.(B) qRT-PCR validation of transcriptional expression of the NF-κB targets NFKB1 and NQO1 during neural specification (n = 3 independent biological repeats; ^∗∗^p ≤ 0.01; ns, not significant; error bars, ±SEM).(C) PANTHER meta-analysis of genes correlating with RELA expression in open-access mouse neural differentiation databases (GPL1261 platform).

NF-κB Activity Is Increased during NPC Maturation {#sec2.4}
-------------------------------------------------

To further interrogate the role of NF-κB during neural differentiation, we employed a lentiviral NF-κB-activated firefly luciferase (FLuc)-2A-eGFP expressing reporter vector (LNT-NFκB-FLuc/EGFP) to assess NF-κB activity in living, differentiating cultures. Feeder-free hESCs were transduced with LNT-NFκB/FLuc-eGFP. hESCs containing a single genomic integration of the NFκB-eGFP expression cassette were subjected to our neural differentiation protocol and GFP^+^ cells were observed only at the NPC stage ([Figure 3](#fig3){ref-type="fig"}A). In future experiments, we employed a further iteration of the NF-κB reporter cassette containing a secreted luciferase variant; NanoLuc, to measure real-time NF-κB activity in living differentiating NPC cultures (LNT-NFKB-NanoLuc/EGFP, [Figure 3](#fig3){ref-type="fig"}B). Interestingly, GFP amplification was only observed after extended passage of NPC, implying a maturation process ([Figures 3](#fig3){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}D). By quantifying NFκB-NanoLuc activity we were able to separate early-passage (P2) NFκB^low^ and later-passage (P9) NFκB^high^ NPC populations ([Figure 3](#fig3){ref-type="fig"}C) for phenotypic comparison. Although morphologically similar, NFκB^low^ NPC were broadly *SOX2*^+^*/LIN28*^+^*/Nestin*^+^ whereas NFκB^high^ NPC were *SOX2*^−^*/LIN28*^−^*/Nestin*^+^ ([Figure 3](#fig3){ref-type="fig"}D). Fluorescence-activated cell sorting (FACS) analysis to elucidate lineage and commitment of NFκB^high^ and NFκB^low^ NPCs demonstrated that in NFκB^high^ NPCs, a large portion of the cells (73%) stained positively for Nestin but the neuronal marker, β-III-tubulin, was not expressed in a large fraction of the population (2.9%) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Moreover, only a small proportion of the NF-κB positive cells expressed the neural crest marker, SOX10 (6.8%). Similarly, in NF-κB-negative NPCs, Nestin was present in 69% of cells and β-III-tubulin and SOX10 were expressed in only a small fraction of cells (9.4% and 0.02%, respectively) ([Figure S2](#mmc1){ref-type="supplementary-material"}B). We demonstrated that this observation is not specific to the Shef3 hESC line. Shef6 hESCs behaved in a similar manner; when subjected to neural induction media, rosettes developed and early-passage NPCs stained positively for SOX2 and Nestin ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Moreover, we observed a significant upregulation of NF-κB signaling in NPC by P6, using the LNT- NFκB-NanoLuc reporter ([Figure S3](#mmc1){ref-type="supplementary-material"}B).Figure 3NF-κB Activity Modulates Metabolic Activity during Neural Specification(A) Schematic representation of the lentiviral reporter system used to quantify NF-κB activity during NPC passage. Scale bars, 100 μm.(B) Lentiviral NFκB-NanoLuc/EGFP reporter assay during neural specification shows NF-κB activation at the NPC stage.(C and D) Lentiviral NFκB-NLuc quantitative assay on living, differentiating cultures during serial passage of NPCs (n = 3 independent biological repeats; ^∗∗∗^p ≤ 0.001; error bars, ±SEM) (C). NFκB^low^-NPC were characterized between P1 and P3 and NFκB^high^-NPC from P5 to P8. (D) Comparison of NFκB^low^- and NFκB^high^-NPC by qRT-PCR of the neural stem cell markers *SOX2* and *LIN28A* and *B*, and *Nestin* (n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.01; error bars, ±SEM).(E--H) qRT-PCR for *GLUT1*, *LDHA*, *PKM2*, *UCP2*, and *ATP Synthase* expression (n = 3 independent biological repeats; error bars, ±SEM), glycolysis as measured by peak medium ^3^H~2~O in NPCs loaded with radiolabeled \[5-^3^H\]glucose (F), medium lactate (G), and PPP (H) as assessed by quantifying the ratio of \[1-^14^C\]glucose conversion to ^14^CO~2~ by decarboxylation through 6-phosphogluconate dehydrogenase compared with \[6-^14^C\]glucose decarboxylation through the TCA cycle (n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗∗^p ≤ 0.001; error bars, ±SEM).(I--L) OXPHOS as measured by the increased percentage of cells sensitive to oligomycin (I) (n = 3 independent biological repeats), Seahorse Bioanalyzer Mitostress test (Ji and Jii), MitoTracker staining (K), and ROS/SO/NO analysis (L) using a quantifiable fluorescent assay (n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001; error bars, ±SEM).

Metabolic Reprogramming Occurs as NPCs Assume a Maturation Phenotype {#sec2.5}
--------------------------------------------------------------------

We endeavored to resolve NFκB^low^ and NFκB^high^-NPC phenotypes at the metabolic level. The glucose transporter *GLUT1* and the mitochondrial uncoupling protein *UCP2* were both transcriptionally downregulated whereas mitochondrial ATP synthase showed a \>10-fold increase indicative of a molecular switch to OXPHOS ([Figure 3](#fig3){ref-type="fig"}E). We assessed glucose distribution during NPC maturation from NFκB^low^- to NFκB^high^-NPC. Glycolysis was compared specifically by measuring peak medium ^3^H~2~O in NPCs loaded with radiolabeled \[5-^3^H\]glucose and was found to be unchanged ([Figure 3](#fig3){ref-type="fig"}F). A single hydrogen atom of H~2~O is interchanged with \[^3^H\] in \[3-^3^H\]glucose at the triose-phosphate isomerase-catalyzed reaction in the glycolytic process. This results in pyruvate production, which is then either converted to lactate or fed into the mitochondrial TCA cycle. Medium lactate was measured and found to be significantly decreased in NFκB^high^ compared with NFκB^low^-NPC ([Figure 3](#fig3){ref-type="fig"}G), suggesting that pyruvate is being preferentially distributed to the TCA cycle. We further assessed anabolic utilization of glucose via the PPP in NPCs by quantifying the ratio of \[1-^14^C\]glucose conversion to ^14^CO~2~ by decarboxylation through 6-phosphogluconate dehydrogenase compared with \[6-^14^C\]glucose decarboxylation through the TCA cycle. Interestingly, the PPP was significantly increased in NFκB^high^-NPC, suggesting that glucose is also redistributed to the PPP during NPC metabolic reprogramming ([Figure 3](#fig3){ref-type="fig"}H).

We also assessed mitochondrial activity in NPCs by direct inhibition of ATP synthase using oligomycin A and measuring ATP production ([Figure 3](#fig3){ref-type="fig"}I), as well as carrying out a "MitoStress test" using the Seahorse Bioanalyzer ([Figures 3](#fig3){ref-type="fig"}Ji and 3Jii). In both experiments, we observed a significant increase in the contribution of OXPHOS to ATP production between NFκB^low^- and NFκB^high^-NPC. We saw similar metabolic function in Shef6-derived NPCs, where NFκB^high^-NPC had a significantly higher spare mitochondrial capacity when compared with NFκB^low^-NPC ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

Furthermore, MitoTracker staining in NPCs showed evidence of a greater mitochondrial load in NFκB^high^-NPC ([Figure 3](#fig3){ref-type="fig"}K). We compared reactive oxygen species (ROS), superoxide (SO), and nitric oxide (NO) production in NFκB^low^- and NFκB^high^-NPC and found that all three species were significantly upregulated ([Figure 3](#fig3){ref-type="fig"}L), further corroborating the increase in mitochondrial activity that we observed in NFκB^high^-NPC. NF-κB also induces the upregulation of NO via NO synthases in hepatocytes ([@bib10]) and promotes glucose 6-phosphate dehydrogenase induction in astrocytes ([@bib8]). Our data in NPCs are consistent with these previous observations and suggest that a similar mechanism is active in committed NPCs.

Autophagic Flux Is Reduced during NPC Maturation {#sec2.6}
------------------------------------------------

We interrogated alterations in degradative capacity between NFκB^low^- and NFκB^high^-NPC by investigating autophagy under different nutrient conditions. As one might expect, starvation increased autophagic flux and, subsequently, the ratio of LC3-II to LC3-I in NFκB^low^-NPC. Moreover, blocking autophagosome-lysosome fusion and degradation with bafilomycin A (Baf) treatment shunted autophagic flux, causing further accumulation of LC3-II ([Figures 4](#fig4){ref-type="fig"}Ai, 4Aii, and [S5](#mmc1){ref-type="supplementary-material"}). However, in NFκB^high^-NPC under normal and serum-starvation conditions we saw increased LC3-II levels, but blocking autophagy with Baf had little effect alone or an additive effect to serum starvation. This would imply that autophagic flux is lower in NFκB^high^-NPC compared with NFκB^low^-NPC. Critically, induction of NF-κB by tumor necrosis factor α (TNFα)/IKK-2 induction in NFκB^low^-NPC resulted in an accumulation of the p62 protein, an indication of autophagic block ([Figure 4](#fig4){ref-type="fig"}B).Figure 4NF-κB Activity Modulates Autophagy during Neural Specification(Ai and Aii) NFκB^High^- and NFκB^low^-NPC populations were compared for LC-3 activation status by western blot in normal media conditions, after treatment with bafilomycin A, under starvation conditions, or with both starvation and bafilomycin A treatment (n = 3 independent biological repeats ± SEM).(B and C) p62 accumulation in NFκB^high^- and NFκB^low^-NPCs stimulated with IKK2 and TNFα (B) and P70S6K (P70) phosphorylation (C) was assessed by western blot under the same conditions as described in (A).(D) TFEB-NanoLuc/EGFP reporter activity assay (n = 3 independent biological repeats; ^∗∗∗^p ≤ 0.001; error bars, ±SEM).(E) LAMP1 staining.

We also evaluated the activity of mammalian target of rapamycin complex 1 (mTORC1) by comparing phosphorylation of its target P70S6K in NPCs. In normal culture conditions, there appeared to be similar levels of P70S6K phosphorylation that was abolished by upregulation of autophagy after serum starvation, and partially restored by blocking autophagic flux with Baf treatment ([Figure 4](#fig4){ref-type="fig"}C). A decrease in autophagic flux would be consistent with increased mTORC1 activity, and we indeed observed an increase in phosphorylated P70S6K under normal conditions after Baf treatment. Lysosomal biogenesis is controlled by transcription factor E box (TFEB) where nuclear translocation is itself inhibited by mTORC1-mediated phosphorylation. We used a TFEB-activated transcription factor-activated reporter (TFAR) lentiviral expression cassette to assay for TFEB nuclear translocation in NPCs and surprisingly saw that it was \>7-fold higher in NFκB^high^-NPC compared with NFκB^low^-NPC ([Figure 4](#fig4){ref-type="fig"}D). LAMP1 immunostaining confirmed a higher density of lysosomes in NFκB^high^-NPC ([Figure 4](#fig4){ref-type="fig"}E).

Cell-Cycle Arrest Occurs as NPCs Assume a Maturation Phenotype {#sec2.7}
--------------------------------------------------------------

Terminally differentiated mature neurons are post-mitotic and so cell-cycle arrest is another key component of the development process. Although NFκB^low^- and NFκB^high^-NPC continued to express equivalent levels of Nestin and there was no evidence of spontaneously differentiated neurons in either cultures, NFκB^high^-NPC had a lower proliferation index ([Figure 5](#fig5){ref-type="fig"}A) and an increased proportion of cells in G~0~/G~1~ compared with NFκB^low^-NPC ([Figure 5](#fig5){ref-type="fig"}B). Consistently, NFκB^high^-NPC presented with significantly increased senescence-associated β-galactosidase (SA-β-Gal; [Figures 5](#fig5){ref-type="fig"}Ci and 5Cii) activity and increased p21 expression ([Figure 5](#fig5){ref-type="fig"}D) without exhibiting an overt change in cell morphology.Figure 5NF-κB Activity Modulates Cell Cycle and p21 during Neural SpecificationCell proliferation by serial cell counts (A) (n = 3 independent biological repeats ± SEM; ^∗∗∗^p ≤ 0.001), PI incorporation (B) (n = 3 independent biological repeats ± SEM, ^∗∗∗^p ≤ 0.001), senescence-associated β-galactosidase assay (Ci and Cii) (n = 3 independent biological repeats \[200 counts/sample\]; ^∗∗∗^p ≤ 0.001; error bars, ±SEM), and p21 immunocytochemistry (D). Scale bars, 100 μm.

NF-κB Modulation Induces a Neural Maturation Phenotype in NPCs {#sec2.8}
--------------------------------------------------------------

To mechanistically link NF-κB activity to neural maturation, metabolic reprogramming, and cell-cycle arrest in NPCs, we again used a combination of IKK-2 transgene expression and exogenous TNFα application to stimulate NF-κB in early-passage NFκB^low^-NPC. Cells transduced with the LNT-NFκB-NanoLuc/EGFP reporter were responsive to both TNFα and IKK-2 induction ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). NFκB^low^-NPC subjected to IKK-2/TNFα treatment significantly decreased *SOX2* and the glycolytic transcript *GAPDH* ([Figure 6](#fig6){ref-type="fig"}A) under maturation conditions. The proportion of ATP production susceptible to oligomycin A inhibition (OXPHOS, [Figure 6](#fig6){ref-type="fig"}B), ROS, and NO accumulation were all increased ([Figures 6](#fig6){ref-type="fig"}C and 6D). TNFα induced p21 in early-passage NPCs to broadly equivalent amounts but IKK2/TNFα treatments appeared to act synergistically to hyperactivate p21 ([Figure 6](#fig6){ref-type="fig"}E). In conclusion, NF-κB activation induces the neural maturation program in NPCs by redirecting glucose metabolism toward mitochondrial respiration for ATP production and the PPP for nucleotide production while slowing the cell cycle prior to any loss of Nestin expression or morphological changes indicative of neural maturation. Remarkably, we consistently observed that NPC would only undergo terminal differentiation to mature neurons after endogenous activation of NF-κB ([Figure 6](#fig6){ref-type="fig"}F). We observed ∼63% of generated β-III-tubulin-positive neurons compared with \<1% in NFκB^low^-NPC ([Figure 6](#fig6){ref-type="fig"}Fii). Furthermore, very few GFAP^+^ cells were present in terminally matured NFκB^high^ neuronal cultures ([Figure S6](#mmc1){ref-type="supplementary-material"}).Figure 6NF-κB Agonists Induce the NFκB^high^-NPC Phenotype in Early-Passage NFκB^low^-NPC(A) *SOX2* and *GAPDH* transcripts in NF-κB modulated NPCs (n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01; error bars, ±SEM).(B--D) Percentage of cells sensitive to oligomycin A (OXPHOS) (B), intracellular NO (C), and ROS activity (D) (all n = 3 independent biological repeats; ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01; error bars, ±SEM).(E) p21 protein as assessed by western blot.(F) (Fi) β-III-Tubulin immunocytochemistry of NFκB^low^- and NFκB^high^-NPC subjected to our standard neural maturation protocol (representative images, n = 3). Scale bars, 100 μm. (Fii) proportion of β-III-tubulin-positive cells in each population (n = 3 independent biological repeats; ^∗∗∗^p ≤ 0.001; error bars, ±SEM).(G) Model of NF-κB activity during neural specification. Upregulation of NF-κB, potentially due to an accumulation of ROS, initiates a feedforward loop increasing mitochondrial biogenesis and respiration, and increased NO production resulting in upregulation of p21, which slows the cell cycle and represses SOX2. NF-κB also inhibits autophagy and increases anabolic PPP to initiate a maturation program capable of efficient differentiation to mature neurons.

Discussion {#sec3}
==========

In our study, we propose a model of neurogenesis whereby endogenous NF-κB activation in committed NPCs induced a maturation phenotype by orchestrating metabolic reprogramming ([Figure 6](#fig6){ref-type="fig"}G). Two recent studies showed that NF-κB signaling promotes mouse hippocampal NSC differentiation when extrinsically activated by inflammation ([@bib39]) ([@bib20]). However, neither study explored the molecular mechanisms underlying NFκB-mediated differentiation.

We were able to discriminate between two discrete populations of proliferating NPC, NFκB^high^- and NFκB^low^-NPC. Although maintained in medium containing heparin and FGF2, NFκB^high^-NPC expressed lower levels of multipotency markers, demonstrated an elongated cell cycle, and more efficiently generated neurons compared with their NFκB^low^ counterparts. Simultaneous loss of multipotency and slowing of the cell cycle toward terminal maturation has only previously been observed after induction with exogenous molecules such as dbCAMP or retinoic acid ([@bib11], [@bib31], [@bib22], [@bib28], [@bib3]).

The metabolic profile of our two NPC populations also differed significantly; the mitochondrial function of NFκB^high^-NPC was characteristically similar to that of neurons. NFκB^high^-NPC had elongated mitochondria and increased mitochondrial membrane potential, and were significantly more dependent on OXPHOS for energy production compared with NFκB^low^-NPC.

Upon exogenous NF-κB activation in NFκB^low^-NPC we saw a significant increase in energy production by OXPHOS. Metabolic reprogramming, PPP, and pyruvate production have all been shown to be influenced by canonical NF-κB (p65/p50) signaling in a variety of diverse contexts ([@bib8], [@bib24]). The increased PPP activity and decreased lactate release observed in the NFκB^high^-NPC is consistent with the typical glycolysis-to-PPP switch previously described in differentiated neurons ([@bib13]). Although there was no change observed in glycolysis, the decreased lactate release reflects increased pyruvate oxidation by mitochondria in NFκB^high^-NPC. Energy production via OXPHOS results in the production of ROS, specifically SO, and NO that is potentially toxic to cells at elevated concentrations but crucially also act as important second messengers in signal transduction ([@bib18]). The induction of OXPHOS by NF-κB stimulation in NFκB^low^-NPC implied a consequential increase in ROS and NO levels. As anticipated, we did observe either a direct or indirect oxidative stress response to NF-κB activity. ROS and NO have been shown to induce cell signaling pathways in normal neural development without inducing cell death ([@bib32]). When NO is present alongside SO, peroxynitrite acts as a pro-oxidant agent able to activate protective antioxidant pathways, including the PPP ([@bib9]), which may explain the absence of apoptosis in our cultures. Interestingly, both increased ROS and NO have been shown to induce p21-mediated cellular senescence through independent mechanisms ([@bib16], [@bib27]). Furthermore, two recent studies have shown in ESCs and NSCs that, when expressed, p21 binds the SOX2 promoter to prevent expression and induce differentiation ([@bib23], [@bib34]). These studies corroborate our data showing decreased SOX2 and increased p21 expression in NFκB^high^-NPC, and the upregulation of p21 observed in stimulation of NFκB^low^-NPC. Collectively, these data support a hypothesis that a cellular maturation program is combining both metabolic and cell-cycle changes.

NFκB^high^-NPC demonstrated higher levels of autophagic and lysosomal proteins LC3-II and LAMP1 compared with NFκB^low^-NPC but showed reduced autophagic flux. There is some ambiguity in the literature with regard to the role of autophagic proteins in neural differentiation. An increase in the levels of LC3-II is indicative of either elevated levels of autophagosome synthesis or a reduction in the turnover in autophagosomes. Treatment with Baf confirms that in our NFκB^high^-NPC, LC3-II increase is due to a decline in autophagosome turnover.

Our data fit with the autophagic profile observed in *in vivo* and *in vitro* neurogenesis models. *In vivo* analysis of autophagy proteins in LC3-GFP transgenic mice indicates that autophagy is differentially regulated in organs. In the brain, neurons are resistant to autophagic flux irrespective of nutrient availability ([@bib25]). Moreover, [@bib37] showed that upon treatment with retinoic acid, the levels of LC3-II increase mouse neuroblastoma cells. We noticed a similar increase in LC3-II/I ratio in NFκB^high^-NPC, without the requirement for exogenous maturation stimulants. [@bib19] analyzed the potential association between autophagic flux and OXPHOS and noted that an increase in oxidative phosphorylation resulted in simultaneous elevation in the levels of LC3-II protein. We have shown that NF-κB links OXPHOS and autophagy during neural specification; we demonstrated that NF-κB induces an upregulation of key autophagy protein p62, which has recently been linked in a positive feedback loop with NF-κB in a cancer model ([@bib36]).

Although the increase in mTOR activity observed in NFκB^high^-NPC was consistent with the reduction in autophagic flux, we also observed an upregulation in TFEB activity. However, a recent study by Li et al. describes an mTORC1-independent mechanism of TFEB-mediated lysosomal biogenesis via PKC ([@bib21]) and it is plausible that NF-κB/PKC is stimulating lysosomal activity in an mTORC1-independent manner.

In summary, we have identified a key role for NF-κB signaling during neural specification of hESCs *in vitro*. It will be important to further substantiate our data *in vivo* by tracking of NF-κB activity during early neurogenesis in order to distinguish how our NPC populations map onto the developing brain. Moreover, it would be fascinating to selectively modulate NF-κB activity in CNS organoid culture to model the consequences of prolonged NF-κB upregulation on CNS development. It would be of great value to assess the effects on neurogenesis in specific CNS lineages, but this was beyond the limitations of our current model. A more complete understanding of the role played by NF-κB in NPC commitment and terminal neural differentiation, as well as the mechanistic contribution of canonical NF-κB signaling to metabolic reprogramming, could result in the establishment of better *in vitro* models of human neural development. Finally, targeting NFκB-mediated neurogenesis could represent a mechanism of preventing depletion of the NSC pool associated with chronic inflammation during normal aging or dementia.

Experimental Procedures {#sec4}
=======================

Maintenance of Cell Lines, MEFs, and Shef3 hESCs {#sec4.1}
------------------------------------------------

The Shef3 and Shef6 hESC line was obtained from the UK Stem Cell Bank under the project SCSC10-48. HEK293T cells were a kind gift from Dr. Steve Howe (Institute of Child Health, University College London) and mouse embryonic fibroblasts (MEFs) were from Cambridge Bioscience (CBA-310). MEFs were cultured in complete medium (DMEM supplemented with 10% \[v/v\] fetal bovine serum, 1× \[v/v\] penicillin/streptomycin, and 1× \[v/v\] non-essential amino acids \[NEAA\]). MEFs were mitotically inactivated with mitomycin C (0.1 μg/mL) (all from Sigma). MEFs were seeded at a density of 5 × 10^4^ cells/cm^2^ on 0.1% (w/v) gelatin-coated tissue culture dishes. hESCs were maintained on MEFs in hESC medium (DMEM/F12 supplemented with NEAA, 20% knockout serum replacement \[Life Technologies\], 0.1 mM β-mercaptoethanol \[Sigma\], and 10 ng/mL FGF2 \[Peprotech\]). Colonies were mechanically passaged every 5--7 days. hESCs were conditioned to feeder-free culture by TrypLE Express (Gibco) enzyme dissociation and plating at high density (1:1) onto human purified fibronectin (20 μg/mL, Millipore)-coated flasks in mTESR (STEMCELL Technologies). Contaminating inactivated MEFs were diluted out within three passages.

Neural Differentiation of hESCs {#sec4.2}
-------------------------------

Feeder-free hESCs (Shef3/Shef6) were replated in neural induction medium (NIM; DMEM/F12, 1× NEAA, 1× N2 supplement \[all from Life Technologies\], 4 mg/mL polyvinyl alcohol \[Sigma\], 2 μg/mL heparin sodium salt \[Sigma\], and 20 ng/mL FGF2) in uncoated, V-shaped 96-well plates at a density of 1 × 10^4^ cells/well. Within 24 hr, neuroepithelial clusters formed. Medium was replaced daily for 5 days; on day 6 aggregates were replated in NIM onto 20 μg/mL laminin (Milipore)-coated dishes to allow neural rosette formation (2--3 days). Neural rosette clusters were mechanically isolated and replated onto laminin-coated dishes in neural expansion medium (NIM plus 1× B27 supplement \[Life Technologies\]). Early- and late-passage NPCs were cultured in the same conditions. All cells were cultured in atmospheric oxygen. NPCs were passaged 1:3 using TrypLE. To direct terminal differentiation of neural cells, we replated NPCs onto a thin layer of Matrigel at a density of 1.3 × 10^4^ cells/cm^2^. Medium was replaced 48 hr later with neural maturation medium (DMEM/F12 \[Life Technologies\], 1× B27, L-glutamine, and 1% horse serum \[both from Sigma\]).

Transcriptomic Microarray {#sec4.3}
-------------------------

RNA was isolated from three biological repeats at the ESC, NEC, NRPC, and NPC stages of differentiation. The whole-genome gene expression array (Human HT-12 v4 Expression BeadChip Kit \[Illumina\]) was processed with quality control assessment by Dr. Jayne Dennis (School of Biological and Chemical Sciences, Queen Mary University of London). The GPLOTS package in R studio generated heatmaps of normalized data where log~2~(x) was plotted; mean was set to 0 and SD to 1. Public microarray data obtained from Affymetrix Mouse Genome 430 2.0 chips (accession number GEO: [GPL1261](ncbi-geo:GPL1261){#intref0010}) were downloaded from the NCBI GEO ftp site. Custom Unix/Linux and R version 2.0 scripts were developed, filtered, and analyzed by packages built by Bioconductor (R) to access the data. The scripts were designed to isolate microarray data obtained from experiments with keywords such "neural stem," "neural progenitor," or "neuron." Raw data (cel files) were corrected for background and normalized using the Bioconductor "GCRMA" package. The R studio "cor" function was used to generate correlation matrices using the Pearson method. Subsequent data from the meta-analyses and normalized data from the Illumina microarray were assessed using [Geneontology.org](http://Geneontology.org){#intref0015}, the PANTHER classification system KEGG 2015, and EnrichR.

Metabolic Analysis Using Cell Titer Glo Assay and Seahorse XFp Platform {#sec4.4}
-----------------------------------------------------------------------

The Cell Titer Glo Luminescent Assay (Promega) measuring ATP production was used as described previously ([@bib12]). Oxygen consumption rate (OCR) in NFκB^low^ and NFκB^high^-NPCs was measured using the Seahorse XFp Bioanalyzer (Agilent) Cell Mito Stress Test Kit. Spare respiratory capacity was calculated by normalizing to baseline OCR.

Lactate Production, Glycolytic Flux, and PPP Analysis {#sec4.5}
-----------------------------------------------------

PPP flux was measured in 8-cm^2^ flasks of adherent cells at 60%--70% confluence containing a central microcentrifuge tube with either 0.8 mL of benzethonium hydroxide (Sigma) for ^14^CO~2~ equilibration or 1 mL of H~2~O for ^3^H~2~O equilibration. Incubations were carried out in Krebs Ringer Phosphate buffer (145 mM NaCl, 5.7 mM Na~2~HPO~4~, 4.86 mM KCl, 0.54 mM CaCl~2~, 1.22 mM 33 MgSO~4~ \[pH 7.4\]) containing 5 mM D-glucose (KPRG buffer) at 37°C. To ensure adequate oxygen supply for oxidative metabolism throughout the incubation period, we filled flasks with oxygen before sealing them.

To measure the carbon flux from glucose through the PPP, we incubated cells in KPRG buffer supplemented with 0.5 μCi D-\[1-^14^C\]glucose or \[6-^14^C\]glucose for 90 min as previously described ([@bib13], [@bib29]). Cellular respiration was then terminated by the addition of 0.2 mL of 20% perchloric acid (Merck Millipore) for 40 min before the benzethonium hydroxide (containing ^14^CO~2~) was removed and the radioactivity measured by liquid scintillation counting. PPP flux was calculated as the difference between ^14^CO~2~ production from \[1-^14^C\]glucose (which decarboxylates through the 6-phosphogluconate dehydrogenase-catalyzed reaction) and that of \[6-^14^C\]glucose (which decarboxylates through the TCA cycle) ([@bib13], [@bib17]). Glycolytic flux was measured by assaying the rate of ^3^H~2~O production from \[3-^3^H\]glucose using a similar method but instead incubating cells with 5 μCi D-\[3-^3^H\]glucose in KPRG buffer per flask for 120 min as previously described ([@bib13], [@bib29]). Respiration was then terminated with perchloric acid and by incubating the cells for 96 hr with a microcentrifuge tube containing H~2~O suspended above the cells to allow ^3^H~2~O equilibration. The ^3^H~2~O was then removed and measured by liquid scintillation counting. Under these experimental conditions, 75% of the produced CO~2~ or 28% of the produced ^3^H~2~O was recovered, as previously established ([@bib29]).

ROS and RNS Detection {#sec4.6}
---------------------

IKK2/TNFα-treated or control cells were plated in a 96-well format at a density of 1 × 10^4^ cells/well before quantifying ROS/RNS (reactive nitrogen species) by colorimetric assay (Enzo Life Sciences) according to the manufacturer\'s instructions. Non-overlapping fluorescent detection probes discriminate between global levels of ROS (excitation \[Ex\] 490 nm, emission \[Em\] 525 nm) and superoxide (Ex 550, Em 620 nm). Cellular NO was quantified by fluorescence absorbance (Ex 495 nm, Em 515 nm) as the non-fluorescent precursor diaminofluorescein diacetate (DAF-2-DA) is converted to the fluorescent triazole derivative, DAF-2T in the presence of NO and O~2~.

*In Vitro* Lentiviral Transcription Factor-Activated Reporter Assay {#sec4.7}
-------------------------------------------------------------------

Production of high-titer NF-κB TFAR lentivirus was performed in HEK293T cells as previously described ([@bib1]). hESCs and NRPCs were transduced at an MOI of 25 with the NF-κB TFAR and an MOI of 2.5 of the constitutively active LNT-SFFV-Vluc construct (expressing vargula luciferase) ([Figure 3](#fig3){ref-type="fig"}A). These constructs are described in [@bib12]. Conditioned supernatant was collected after 6 hr. Twenty microliters of sample was combined with 20 μL of luciferase assay buffer (25 mM Tris phosphate \[pH 7.8\], 1 mM DTT, 1 mM EDTA, 1% Triton X-100, 8 mM 6MgCl2, 30% glycerol, 2% BSA) in a white-bottomed plate with technical repeats in triplicate. Samples were injected with either0.5 μg/mL coelenterazine (GoldBio) or 5 nM cypridina luciferin (Nanolight), and photon emissions were measured at 460 nM.

pCMV-IKK2 Plasmid Transfection {#sec4.8}
------------------------------

pLNT NFκB-NanoLuc/EGFP/pLNT-SFFV-Vluc transduced NPCs were transfected using 0.1 mM PEI (PEI/DNA ratio of 1:1) with pCMV-IKK2 (Addgene) and a control, pCMV-FLAG. To detect NF-κB activity, we analyzed the medium by luminometry at the following time points: 24 hr, 48 hr, and 72 hr.

Immunocytochemistry and Live MitoTracker Imaging {#sec4.9}
------------------------------------------------

For fluorescence immunocytochemistry and confocal microscopy, cells were fixed in 4% paraformaldehyde (PFA) or 100% ice-cold MeOH (for confocal). Samples were blocked in 2% BSA in PBS + 0.05% (v/v) Tween 20 (all from Sigma). Antibodies were diluted in blocking buffer (SOX2 1:100 \[\#AF2018\], β-III-tubulin 1:200 \[\#MAB1195\], Nestin 1:200 \[\#MAB1295\] \[all R&D Systems\], LAMP1 1:200 \[Abcam \#Ab24170\], p21 1:400 \[Cell Signaling Technologies \#2947\]) and incubated overnight at 4°C. Secondary antibodies (1:500, all Alexa Fluor) were applied for 1 hr at room temperature. Immunostained cells were mounted with or without DAPI and analyzed using an Olympus IX81 inverted fluorescence microscope or the Leica TCS SP5 X for confocal. Mitochondria were imaged using MitoTracker probes (25 nM) (Life Technologies), following the manufacturer\'s instructions.

qRT-PCR {#sec4.10}
-------

Total RNA was isolated from cells using the RNeasy kit (Qiagen) according to the manufacturer\'s instructions. Random hexamer primers and M-MLV reverse transcriptase (both Promega) were used to reverse transcribe RNA, as per the manufacturer\'s instructions. Triplicate samples were analyzed by the Bio-Rad CFX Connect Real-Time PCR detection system using Fast SYBR Green master mix (Thermo Fisher Scientific) with the appropriate primer sets (0.4 μM, [Table S1](#mmc1){ref-type="supplementary-material"}). Transcript levels were normalized to PABPC4. This target was chosen because in our microarray it showed no normalized alteration in ESC, NEC, NRPC, NPC, and neuronal cultures (our unpublished data).

Western Blotting {#sec4.11}
----------------

Total protein was quantified using the Bio-Rad Protein Assay. Lysates were resolved on SDS-PAGE and electrotransferred onto Hybond-enhanced chemiluminescence (ECL) nitrocellulose membrane (Amersham Biosciences). The membrane was blocked in 5% BSA in PBS + 0.05% Tween 20 and incubated overnight in primary antibody p21 (1:1,000, Cell Signaling \#2947), β-actin (1:4,000, Sigma \#A2228), pP70S6K (1:1,000, Cell Signaling \#108D2) anti-P70S6K (1:1,000, Stressgen \#KAP-CC035), LC3 (1:1,000 Novus Biologicals \#NB100-2220), p62 (1:1,000, Abcam \#Ab56416) at 4°C. Blots were incubated with the appropriate horseradish peroxidase-conjugated secondary antibody (Dako, 1:2,000) in blocking buffer for 1 hr at room temperature. The membrane was developed using ECL (Pierce/Amersham) according to the manufacturer\'s instructions. Densitometric quantification was performed on unsaturated images in ImageJ (NIH).

Flow Cytometry {#sec4.12}
--------------

Cell cycle was assayed in control or IKK-2/TNFα-treated NPCs using propidium iodide (PI) (Sigma). Cells were dissociated in TrypLE, resuspended in PBS, and centrifuged at 900 rpm for 8 min. Supernatant was discarded and 1 mL of fixative (70% ethanol) was added drop-wise while vortexing. Cells were incubated in fixative for 30 min at 4°C. After centrifugation cells were washed with PBS before the supernatant was discarded and 100 μL of a 100 μg/mL stock solution of Rnase A was used to resuspend the cells. Four hundred microliters of a 50 μg/mL stock of PI was added and the reaction was incubated in darkness for 10 min prior to analysis. PI staining was analyzed using a Becton Dickinson (BD Bioscience) FACScalibur flow cytometer and CellQuest Pro analysis software (BD Bioscience). For detection of neural markers in LNT NFκB-NanoLuc/EGFP transduced cells, cultures were trypsinized, washed in PBS, and resuspended in 4% PFA for 20 min at room temperature. Samples were permeabilized in 0.3% Triton X-100 and blocked in 2% BSA (Sigma-Aldrich) + 0.05% (v/v) Tween 20. Antibodies were diluted in blocking buffer (SOX10 1:100 \[\#AF2864\], β-III-tubulin 1:200 \[\#MAB 1195\], Nestin 1:200 \[\#MAB1259\] \[all R&D Systems\]), and incubated for 1 hr at room temperature. Untransduced NPCs and immunoglobulin G from mouse and goat serum were used as negative controls (Sigma \#I5381, \#I5006). Secondary antibodies (1:500, all Alexa Fluor \#647) were applied for 1 hr at room temperature and samples were washed prior to FACS analysis.

Senescence-Associated β-Galactosidase Assay {#sec4.13}
-------------------------------------------

NPCs were fixed for 5 min with 0.5% (v/v) glutaraldehyde (pH 7.2), washed in PBS supplemented with 1 mM MgCl~2~, and incubated in β-galactosidase solution (120 μM potassium ferricyanide/potassium ferrocyanide \[pH 7.0\] and 1 mg/mL X-gal) at 37°C overnight. After incubation, cells were washed in an appropriate volume of PBS and analyzed by bright-field microscopy.

Statistical Analysis {#sec4.14}
--------------------

Statistical analysis of *in vitro* vector analysis data, qPCR, and metabolic assays was performed using an unpaired Student\'s two-tailed t test. Two-way ANOVA was employed for [Figure S4](#mmc1){ref-type="supplementary-material"}B. All data are expressed as mean values ± SEM, with each sample being measured at least in triplicate.
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